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A novel I2-catalyzed one-pot multicomponent protocol for the synthesis of a variety of elusive furo[2,3-b]
pyrrole and thieno[2,3-b]pyrrole libraries has been established. To date, cyclization among alkanone,
hydrazine and 2-bromobenzofuran or 2-bromobenzo[b]thiophene has not been explored in one-pot.
Thus, the proposed single step protocol provides a versatile alternative to existing routes for accessing
useful furo[2,3-b]pyrrole and thieno[2,3-b]pyrrole libraries.
© 2018 Elsevier Ltd. All rights reserved.1. Introduction
Pyrrole cores are prevalent foundational building blocks in
many biologically active molecules, natural products and drugs.
They exhibit interesting biological proﬁles such as antitumour,1
antibacterial,2 muscle relaxant, tranquilizers,3 antifungal,4 anti-in-
ﬂammatory,5 antimicrobial,6 analgesic,7 chemotherapeutic,8 anti-
glaucoma,9 neurodegenerative and psychiatric disorder10 drugs.
Pyrrole scaffolds like Tensidol A and Tensidol B showed miconazole
activity as well as antimicrobial activity.4a Lysine (K)-speciﬁc
demethylase 1A (KDM1A) is an anticancer drug (Fig. 1).4b A family
of pyrrole exists as a key structural motif in the construction of
hallucinogen and serotonin agonists.5 It should be noted that pyr-
role ring systems have been attracted researchers to design light
emitting diodes and transistors.11 Considering these impressive
biological and chemophysical properties of pyrrole derivatives and
their signiﬁcant role in organic synthesis, the development of
versatile, convenient, and efﬁcient methods for the synthesis of
these core moieties has been attracted considerable attention from
both the academic and industrial communities. The classical routes
to pyrrole-fused heterocyclic system proceeded from the (i)ivashankar).reaction of O-phenyl-conjugated oxime ether with an alkyl
radical,12 (ii) Baldwin's cyclization of 3-substituted pyrrolidine-
diones,13 (iii) thermolysis of the methyl 2-azido-3-(3-furyl)prope-
noate,14 (iv) reaction between 1,2-diaza-1,3-butadienes and diethyl
or dimethyl acetylsuccinate,15 (v) Gewald reaction of 1,3-dicarbonyl
compound, alkyl or aryl isothiocyanates via ketene N,S-acetal in-
termediate, followed by a Dieckmann type cyclization,16 (vi)
reductive cyclization of 3-(2-nitrophenyl)thiophenes via nitrene
intermediates,17 (vii) radical or palladium catalyzed cyclization of
3-(2-bromoindol-3-yl)acrylonitriles.18 Despite these advances, to
the best of our knowledge, the utilization of three-component
domino reaction strategy for the construction of furo[2,3-b]pyr-
roles and thieno[2,3-b]pyrroles has not yet been documented. Thus,
it is highly desirable to develop an easy and efﬁcient protocol to
construct these novel structural units in one-pot, especially with
the readily available starting materials.
Usually iodine catalyzed reactions are preferred over metal
catalyzed reactions due to low cost, being environmentally benign,
operational simplicity and to avoid the need of removal of metal
impurities. Several research groups have been used iodine as a
catalyst in various organic transformations such as the Lieben
iodoform reaction, iodolactonization reactions, dehydration of
diacetone alcohol, Michael reactions,19 oxidative cyclization of
acylhydrazones,20 and for the synthesis of imino-1,2,4-
Fig. 1. Examples of some pyrrole based pharmacologically active molecules.
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organic reactions using molecular iodine.22
As part of an ongoing development of efﬁcient protocols for the
preparation of signiﬁcant heterocycles23 and in a continuation of
our work on multicomponent reactions,24 herein, we report a sin-
gle, unique method for the preparation of both furo[2,3-b]pyrroles
and thieno[2,3-b]pyrroles using a single step, one-pot protocol. The
yields are higher than the previous multistep protocols,25 making
this method advantageous for the synthesis of these fused het-
erocyclic motifs.2. Results and discussion
The reaction of 2-bromobenzofuran (1a), butan-2-one (2a), and
hydrazine (3) in THF under reﬂux condition was selected as the
model reaction to establish the best reaction conditions. The re-
action did not proceed without any catalyst. In the presence of, to
our delight, tetrabutylammonium iodide (TBAI) and potassium io-
dide (KI) yielded 22% and 26% of the desired compound (4a)
respectively. However, other catalysts like cerium ammonium ni-
trate (CAN), Co3O4, BiCl3, and ZrCl3 found to be ineffective and give
an unsatisfactory result under the same reaction conditions. It was
found that iodine showed catalytic efﬁciency better than others and
produced the best result of the expected 2,3-dimethyl-1H-benzo-
furo[2,3-b]pyrrole (4a) in near quantitative yield (69%).
Next, we screened the reaction conditions with a range of sol-
vents, forward yield improvement, and the results are summarized
in Table 1. Among all, ethanol revealed to be a signiﬁcantly better
choice and proceeded more rapidly to afford the desired product in
quantitative yield. Having established the suitable catalyst and
solvent for the synthesis of benzofuro[2,3-b]pyrrole, we then
focused on the amount of iodine. Increasing the loading of iodine
resulted in the desired product 4a in high yields, and the use of
10mol% of catalyst delivered the best result (Table 1, entry 16).
With further increase of iodine loading into 20mol%, the yield of 4a
was not augmented. The reaction temperature played a signiﬁcant
role in this process. Thus, improvement of product yield was
observed in ethanol at reﬂux.
Then taking the molar ratio at 1:1:1.1 of 1a/2a/3, catalyzed by
10mol% iodine in ethanol at reﬂux temperature for 2 h. The desired
product 4a could be obtained in 81% yield.
The scope and limitations of this three component reaction
under the optimized reaction conditions were studied using a va-
riety of alkanones and 2-bromobenzofurans with hydrazine as
summarized in Table 2. First the inﬂuence of substituents inalkanone was investigated. As expected, all the alkanones gave the
corresponding benzofuro[2,3-b]pyrroles in excellent yields. Cyclo-
alkanones (4h, 4i& 4k) provided the corresponding benzofuro[2,3-
b]pyrrole in excellent yield compared to those acyclic ketones. It
should be noted that heterocyclic ketones as well as N-substituted
heterocyclic ketone were well tolerated under this reaction con-
ditions, and the desired benzofuro[2,3-b]pyrrole motifs were ob-
tained in excellent yields (4i¡4k).
Under this optimized conditions, the scope of 2-
bromobenzofuran was also explored. 2-Bromobenzofuran having
electron withdrawing group underwent this cyclization smoothly
to afford the cyclized product (4l¡4o) in good yields. In addition,
the feasibility of this protocol was also extended by utilizing 2-
bromobenzo[b]thiophene (1c), giving the target compounds
(4p¡4t) in good yields.
In the light of above experimental observations and literature
reports,25 a mechanistic rationalisation is depicted in Scheme 1. The
ﬁrst step involves the nucleophilic attack of hydrazine on activated
2-bromobenzofuran to give an intermediate. The intermediate
formed undergo condensation reaction with activated carbonyl
compound to form the corresponding hydrazones. This is followed
by the [3,3] sigmatropic rearrangement to afford enehydrazine
intermediate, which forms a cyclic aminoacetal (or aminal). Elim-
ination of NH3 gives the desired benzofuro[2,3-b]pyrrole product.
The presence of iodine is likely to enhance the rate and yield of this
one-pot synthesis.3. Conclusion
In summary, we have developed a facile and an efﬁcient
multicomponent tandem cyclization reaction for the direct syn-
thesis of benzofuro[2,3-b]pyrrole and thieno[2,3-b]pyrrole motifs
via a Fischer-type cyclization. This cyclization has not been
explored in one-pot. The present single step protocol provides a
versatile alternative to existing multistep routes for accessing
useful furo[2,3-b]pyrrole and thieno[2,3-b]pyrrole libraries.4. Experimental
4.1. General information
Unless otherwise noted, purchased chemicals were utilized
without further puriﬁcation. Melting points were obtained on an
electric melting point apparatus and values are uncorrected. TLC
was performed using commercially available 100e400 mesh silica
Table 1
The optimization of the multicomponent reaction.
Entry Catalyst Amount of catalyst (mol%) Solvent Time (hr) Temp (C) Yield (%)
1 No catalyst e THF 24 Reﬂux 0
2 CAN 10 THF 10 Reﬂux 12
3 Co3O4 10 THF 10 Reﬂux 5
4 BiCl3 10 THF 10 Reﬂux 7
5 ZrCl3 10 THF 10 Reﬂux 15
6 TBAI 10 THF 10 Reﬂux 22
7 KI 10 THF 10 Reﬂux 26
8 I2 10 THF 10 Reﬂux 69
9 I2 10 THF 24 RT 0
10 I2 10 No solvent 24 Reﬂux 0
11 I2 10 1,4-dioxane 4 Reﬂux 42
12 I2 10 DMSO 4 Reﬂux 48
13 I2 10 Toluene 4 Reﬂux 51
14 I2 10 CH3CN 4 Reﬂux 49
15 I2 10 Ethanol 4 Reﬂux 81
16 I2 10 Ethanol 2 Reﬂux 81
17 I2 20 Ethanol 2 Reﬂux 81
18 I2 3 Ethanol 4 Reﬂux 40
19 I2 5 Ethanol 4 Reﬂux 52
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Cary 630 FT-IR spectrophotometer. 1H NMR (400MHz) and 13C
NMR (100MHz) spectra were obtained on Bruker WH-200 spec-
trometer, Agilent spectrometer and JEOL spectrometer using CDCl3
(proton d 7.26 and carbon d 77.23) as solvent and TMS
(d¼ 0.00 ppm) as an internal standard at room temperature.
Chemical shifts were expressed in parts per million (ppm) and
coupling constant (J) in hertz (Hz). Multiplicity was indicated as
follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet).
Mass spectra were recorded on an Agilent LC-MS. Using ESI mode,
HRMS spectra were recorded. Mass analyzer used for the HRMS
measurements was TOF. Elemental analysis was performed on an
Elemental Vario Micro Cube rapid analyzer.
4.2. General experimental procedure for the synthesis of (4a -t)
To a stirred solution of 2-bromobenzofuran/2-bromobenzo[b]
thiophene (2.53mmol) in ethanol (5mL) was added hydrazine
(0.08 g, 2.53mmol), I2 (0.03 g, 10mol%) and alkanone (2.53mmol).
The reaction mixture was reﬂuxed for 1e3 h. After completion of
the reaction as monitored by TLC, the reaction mixture was
quenched with a saturated aqueous solution of Na2S2O3. The
organic and aqueous layers were then separated. The aqueous layer
was extracted with ethyl acetate (3 50mL). The extract was
washed with water and ﬁnally with brine. The organic layer was
dried over anhydrous Na2SO4 and concentrated by rotary evapo-
rator. Finally, the residue was puriﬁed by recrystallization from
ethanol.
4.2.1. 2,3-Dimethyl-1H-benzofuro[2,3-b]pyrrole (4a)
Yield 81% (376mg); White solid; mp: 220e222 C; IR (ATR,
cm1): 3376 (NH); 1H NMR (CDCl3, 400MHz) d: 2.07 (s, 3H, CH3),
2.30 (s, 3H, CH3), 5.00 (s, 1H, NH), 7.38 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.52
(t, 1H, J¼ 6.8 Hz, Ar-H), 7.69 (d, 1H, J¼ 9.6 Hz, Ar-H), 7.90 (d, 1H,J¼ 10 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 8.2, 11.7, 103.3,
106.9, 112.1, 120.8, 123.2, 124.4, 127.3 (2C), 145.9, 157.2 ppm; LCMS
m/z: [MþH]þ Calcd for C12H12NO 186.08; Found 186.10; Anal. Calcd
for C12H11NO: C, 77.81; H, 5.99; N, 7.56. Found: C, 77.75; H, 5.90; N,
7.51.
4.2.2. 2-Ethyl-3-methyl-1H-benzofuro[2,3-b]pyrrole (4b)
Yield 80% (402mg); Yellow solid; mp: 210e212 C; IR (ATR,
cm1): 3379 (NH); 1H NMR (CDCl3, 400MHz) d: 1.18 (t, 3H,
J¼ 7.2 Hz, CH3 of ethyl group), 2.06 (s, 3H, CH3), 3.00e3.07 (q, 2H,
J¼ 8.4 Hz, CH2 of ethyl group), 5.05 (s,1H, NH), 7.37 (t,1H, J¼ 7.6 Hz,
Ar-H), 7.45 (t, 1H, J¼ 6.8 Hz, Ar-H), 7.68 (d, 1H, J¼ 9.2 Hz, Ar-H), 7.81
(d, 1H, J¼ 10 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 8.6, 14.7,
23.5, 101.9, 106.1, 111.0, 120.0, 123.1, 124.9, 126.8, 127.6, 145.0,
156.5 ppm; HRMS m/z: [MþH]þ Calcd for C13H14NO 200.2500;
Found 200.2412; Anal. Calcd for C13H13NO: C, 78.36; H, 6.58; N,
7.03. Found: C, 78.31; H, 6.49; N, 6.91.
4.2.3. 2-Methyl-3-propyl-1H-benzofuro[2,3-b]pyrrole (4c)
Yield 82% (442mg); White solid; mp: 209e211 C; IR (ATR,
cm1): 3374 (NH); 1H NMR (CDCl3, 400MHz) d: 0.98 (t, 3H,
J¼ 7.2 Hz, propyl CH3), 1.57e1.68 (m, 2H, CH2), 2.20 (s, 3H, CH3),
2.58 (t, 2H, J¼ 6.8 Hz, CH2), 5.07 (s, 1H, NH), 7.42 (t, 1H, J¼ 7.6 Hz,
Ar-H), 7.55 (t, 1H, J¼ 7.2 Hz, Ar-H), 7.69 (d, 1H, J¼ 8.8 Hz, Ar-H), 7.91
(d, 1H, J¼ 10.4 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 11.9,
13.7, 25.5, 28.4, 106.7, 110.5, 120.8, 121.9, 123.3, 124.8, 127.5 (2C),
145.2, 156.9 ppm; LCMS m/z: [MþH]þ: Calcd for C14H16NO 214.28;
Found 214.4; Anal. Calcd for C14H15NO: C, 78.84; H, 7.09; N, 6.57.
Found: C, 78.78; H, 7.00; N, 6.49.
4.2.4. 3-Isopropyl-2-methyl-1H-benzofuro[2,3-b]pyrrole (4d)
Yield 87% (470mg); White solid; mp: 224e226 C; IR (ATR,
cm1): 3372 (NH); 1H NMR (CDCl3, 400MHz) d: 1.20 (d, 6H,
J¼ 9.6 Hz, i-propyl CH3), 2.10 (s, 3H, CH3), 2.96e3.05 (m, 1H, i-
Table 2
Synthesis of benzofuro[2,3-b]pyrrole and thieno[2,3-b]pyrrole motifs.
Entry R1 X Ketone Product Time (hr) Yield (%)
1 H O 4a 2 81
2 H O 4b 2 80
3 H O 4c 2.5 82
4 H O 4d 1.5 87
5 H O 4e 2 84
6 H O 4f 1 90
7 H O 4g 2.5 81
8 H O 4h 1 92
9 H O 4i 1 91
10 H O 4j 2.5 86
Table 2 (continued )
Entry R1 X Ketone Product Time (hr) Yield (%)
11 H O 4k 2 89
12 5-NO2 O 4l 2.5 79
13 5-NO2 O 4m 2 81
14 5-NO2 O 4n 3 79
15 5-NO2 O 4 2 85
16 H S 4p 3 82
17 H S 4q 1.5 90
18 H S 4r 2 83
19 H S 4s 3 84
20 H S 4t 2.5 91
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J¼ 6.8 Hz), 7.81 (d, 1H, J¼ 9.2 Hz), 8.01 (d, 1H, J¼ 8.8 Hz) ppm; 13C
NMR (CDCl3, 100MHz) d: 12.0, 24.8 (2C), 29.9, 106.9, 111.4, 118.3,
120.7, 123.8, 124.7, 127.7 (2C), 145.2, 156.5 ppm; LCMSm/z: [MþH]þ
Calcd for C14H16NO 214.28; Found 214.2; Anal. Calcd for C14H15NO:
C, 78.84; H, 7.09; N, 6.57. Found: C, 78.79; H, 7.01; N, 6.52.4.2.5. 2,3-Diethyl-1H-benzofuro[2,3-b]pyrrole (4e)
Yield 84% (452mg); Yellow solid; mp: 229e231 C; IR (ATR,
cm1): 3366 (NH); 1H NMR (CDCl3, 400MHz) d: 0.71 (t, 3H,
J¼ 6.4 Hz), 1.12 (t, 3H, J¼ 7.2 Hz), 2.20e2.26 (q, 2H, J¼ 7.6 Hz),
Scheme 1. Plausible mechanism for the synthesis of 4a - t.
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H), 7.47 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.67 (d, 1H, J¼ 9.6 Hz, Ar-H), 7.91 (d,
1H, J¼ 10Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 14.0, 15.7,
16.6, 23.9, 106.7, 111.5, 120.9, 121.6, 123.5, 124.9, 126.7, 127.8, 145.0,
156.1 ppm; LCMS m/z: [MþH]þ Calcd for C14H16NO 214.28; Found
214.12; Anal. Calcd for C14H15NO: C, 78.84; H, 7.09; N, 6.57. Found: C,
78.78; H, 7.02; N, 6.48.
4.2.6. 3-Tert-butyl-2-methyl-1H-benzofuro[2,3-b]pyrrole (4f)
Yield 90% (518mg); White solid; mp: 225e227 C; IR (ATR,
cm1): 3340 (NH); 1H NMR (CDCl3, 400MHz) d: 1.39 (s, 9H, tert-
butyl), 2.26 (s, 3H, CH3), 4.95 (s, 1H, NH), 7.37 (t, 1H, J¼ 6.8 Hz, Ar-
H), 7.45 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.64 (d, 1H, J¼ 9.2 Hz, Ar-H), 7.74 (d,
1H, J¼ 9.6 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 12.9, 32.8
(3C), 34.7, 106.9, 112.1, 118.5, 120.4, 123.1, 124.0, 127.0 (2C), 145.0,
156.7 ppm; LCMS m/z: [MþH]þ Calcd for C15H18NO 228.3; Found
228.3; Anal. Calcd for C15H17NO: C, 79.26; H, 7.54; N, 6.16. Found: C,
79.19; H, 7.48; N, 6.08.4.2.7. 1,2,3,4-Tetrahydrobenzofuro[2,3-b]cyclopenta[d]pyrrole (4g)
Yield 81% (404mg); White solid; mp: 209e211 C; IR (ATR,
cm1): 3351 (NH); 1H NMR (CDCl3, 400MHz) d: 2.15e2.23 (m, 2H),
2.91 (t, 2H, J¼ 7.6 Hz), 3.24 (t, 2H, J¼ 7.2 Hz), 5.06 (s,1H, NH), 7.37 (t,
1H, J¼ 6.8 Hz, Ar-H), 7.54 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.73 (d, 1H,
J¼ 9.6 Hz, Ar-H), 7.78 (d, 1H, J¼ 9.2 Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 25.4, 26.0, 29.9, 106.3, 111.3, 120.5, 121.9, 123.7, 125.1,
126.9, 127.8, 145.9, 156.5 ppm; LCMS m/z: [MþH]þ Calcd for
C13H12NO 198.08; Found 198.4; Anal. Calcd for C13H11NO: C, 79.16;
H, 5.62; N, 7.10. Found: C, 79.09; H, 5.58; N, 7.05.
4.2.8. 7,8,9,10-Tetrahydro-6H-benzofuro[2,3-b]indole (4h)
Yield 92% (490mg); White solid; mp: 213e215 C; IR (ATR,
cm1): 3358 (NH); 1H NMR (CDCl3, 400MHz) d: 1.36e1.42 (m, 4H),
2.30 (t, 2H, J¼ 6.4 Hz), 2.90 (t, 2H, J¼ 6.8 Hz), 5.14 (s, 1H, NH), 7.38
(t, 1H, J¼ 7.2 Hz, Ar-H), 7.50 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.68 (d, 1H,
J¼ 10 Hz, Ar-H), 7.90 (d, 1H, J¼ 9.2 Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 20.5, 23.1, 23.7 (2C), 106.9, 111.7, 120.5, 121.8, 123.5,
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C14H12NO 210.26; Found 210.2; Anal. Calcd for C14H13NO: C, 79.59;
H, 6.20; N, 6.63. Found: C, 79.50; H, 6.12; N, 6.59.4.2.9. 2,3,4,5-Tetrahydro-1H-benzofuro[30,2':4,5]pyrrolo[3,2-c]
pyridine (4i)
Yield 91% (488mg); Yellow solid; mp: 219e221 C; IR (ATR,
cm1): 3308 (NH), 3362 (NH); 1H NMR (CDCl3, 400MHz) d: 1.92 (s,
1H, Piperidine-NH), 2.78 (t, 2H, J¼ 6.4 Hz), 3.32 (t, 2H, J¼ 7.2 Hz),
3.79 (s, 2H), 5.05 (s, 1H, Pyrrole-NH), 7.35 (t, 1H, J¼ 6.8 Hz, Ar-H),
7.43 (t, 1H, J¼ 6.4 Hz, Ar-H), 7.62 (d, 1H, J¼ 9.6 Hz, Ar-H), 7.73 (d,
1H, J¼ 9.6 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 31.0, 42.6,
45.2, 106.9, 111.5, 118.3, 120.8, 123.2, 124.6, 126.8, 127.9, 145.5,
156.3 ppm; LCMS m/z: [MþH]þ Calcd for C13H13N2O 213.25; Found
213.2; Anal. Calcd for C13H12N2O: C, 73.56; H, 5.70; N, 13.20. Found:
C, 73.50; H, 5.64; N, 13.15.4.2.10. 2-Methyl-2,3,4,5-tetrahydro-1H-benzofuro[30,2':4,5]pyrrolo
[3,2-c]pyridine (4j)
Yield 86% (493mg); White solid; mp: 230e232 C; IR (ATR,
cm1): 3370 (NH); 1H NMR (CDCl3, 400MHz) d: 2.25 (s, 3H, CH3),
2.64 (t, 2H, J¼ 6.4 Hz), 3.04 (t, 2H, J¼ 7.6 Hz), 3.57 (s, 2H), 5.09 (s,
1H, NH), 7.38 (t, 1H, J¼ 6 Hz, Ar-H), 7.50 (t, 1H, J¼ 7.2 Hz, Ar-H), 7.90
(d, 1H, J¼ 9.2 Hz, Ar-H), 7.95 (d, 1H, J¼ 9.6 Hz, Ar-H) ppm; 13C NMR
(CDCl3, 100MHz) d: 28.7, 44.2, 56.2, 57.8, 106.3, 111.9, 118.6, 120.9,
123.5, 124.9, 126.8, 127.6, 145.1, 156.1 ppm; LCMS m/z: [MþH]þ
Calcd for C14H15N2O 227.27; Found 227.4; Anal. Calcd for
C14H14N2O: C, 74.31; H, 6.24; N, 12.38. Found: C, 74.25; H, 6.19; N,
12.32.4.2.11. 1,3,4,5-Tetrahydrobenzofuro[2,3-b]pyrano[3,4-d]pyrrole (4k)
Yield 89% (480mg); Yellow solid; mp: 227e229 C; IR (ATR,
cm1): 3367 (NH); 1H NMR (CDCl3, 400MHz) d: 2.64 (t, 2H,
J¼ 6.8 Hz), 3.75 (t, 2H, J¼ 7.6 Hz), 4.71 (s, 2H), 5.21 (s, 1H, NH), 7.42
(t, 1H, J¼ 6.4 Hz, Ar-H), 7.54 (t, 1H, J¼ 7.6 Hz, Ar-H), 7.72 (d, 1H,
J¼ 9.6 Hz, Ar-H), 7.88 (d, 1H, J¼ 9.2 Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 27.5, 65.1 (2C), 106.4, 111.5, 118.1, 120.8, 123.3, 124.5,
126.6, 128.0, 145.2, 156.7 ppm; LCMS m/z: [M-H]- Calcd for
C13H10NO2 212.23; Found 212.2; Anal. Calcd for C13H11NO2: C,
73.23; H, 5.20; N, 6.57. Found: C, 73.19; H, 5.12; N, 6.52.4.2.12. 2,3-Dimethyl-5-nitro-1H-benzofuro[2,3-b]pyrrole (4l)
Yield 79% (460mg); Yellow solid; mp: 205e207 C; IR (ATR,
cm1): 3359 (NH); 1H NMR (CDCl3, 400MHz) d: 1.92 (s, 3H, CH3),
2.19 (s, 3H, CH3), 4.99 (s, 1H, NH), 7.78 (d, 1H, J¼ 9.2 Hz, Ar-H), 8.09
(d, 1H, J¼ 9.6 Hz, Ar-H), 8.30 (s, 1H, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 8.7, 11.1, 103.2, 107.5, 112.8, 116.1, 120.0, 127.2, 128.7,
145.3, 146.0, 162.3 ppm; LCMS m/z: [MþH]þ Calcd for C12H11N2O3
231.22; Found 231.12; Anal. Calcd for C12H10N2O3: C, 62.60; H, 4.38;
N, 12.17. Found: C, 62.56; H, 4.30; N, 12.13.4.2.13. 3-Isopropyl-2-methyl-5-nitro-1H-benzofuro[2,3-b]pyrrole
(4m)
Yield 81% (528mg); White solid; mp:215e217 C; IR (ATR,
cm1): 3355 (NH); 1H NMR (CDCl3, 400MHz) d: 1.07 (d, 6H,
J¼ 9.2 Hz), 2.10 (s, 3H), 2.81e2.91 (m, 1H), 5.02 (s, 1H, NH), 7.84 (d,
1H, J¼ 9.6 Hz, Ar-H), 8.11 (d, 1H, J¼ 10Hz, Ar-H), 8.44 (s, 1H, Ar-H)
ppm; 13C NMR (CDCl3, 100MHz) d: 12.1, 24.7 (2C), 29.8, 106.9, 112.3,
116.2, 118.1, 120.1, 127.8, 128.2, 145.9 (2C), 162.6 ppm; LCMS m/z:
[MþH]þ Calcd for C14H15N2O3 259.27; Found 259.2; Anal. Calcd for
C14H14N2O3: C, 65.11; H, 5.46; N, 10.85. Found: C, 65.06; H, 5.40; N,
10.79.4.2.14. 8-Nitro-1,2,3,4-tetrahydrobenzofuro[2,3-b]cyclopenta[d]
pyrrole (4n)
Yield 79% (483mg); White solid; mp: 227e229 C; IR (ATR,
cm1): 3358 (NH); 1H NMR (CDCl3, 400MHz) d: 2.20e2.29 (m, 2H),
2.71 (t, 2H, J¼ 6 Hz), 2.96 (t, 2H, J¼ 6.8 Hz), 5.01 (s, 1H, NH), 7.72 (d,
1H, J¼ 9.6 Hz, Ar-H), 7.93 (d, 1H, J¼ 9.2 Hz, Ar-H), 8.21 (s, 1H, Ar-H)
ppm; 13C NMR (CDCl3, 100MHz) d: 25.2, 26.1, 29.8, 106.9, 112.4,
116.7, 120.1, 121.8, 126.6, 128.1, 145.1, 145.9, 162.4 ppm; LCMS m/z:
[M-H]- Calcd for C13H9N2O3 241.23; Found 241.4; Anal. Calcd for




Yield 85% (554mg); White solid; mp: 227e229 C; IR (ATR,
cm1): 3366 (NH); 1H NMR (CDCl3, 400MHz) d: 2.75 (t, 2H,
J¼ 7.6 Hz), 3.65 (t, 2H, J¼ 7.2 Hz), 4.99 (s, 2H), 5.10 (s, 1H, NH), 7.92
(d, 1H, J¼ 9.6 Hz, Ar-H), 8.19 (d, 1H, J¼ 9.2 Hz, Ar-H), 8.56 (s, 1H, Ar-
H) ppm; 13C NMR (CDCl3, 100MHz) d: 27.4, 65.5 (2C), 106.9, 112.8,
116.6, 118.3, 120.2, 126.7, 128.7, 145.2, 145.9, 162.6 ppm; LCMS m/z:
[M-H]- Calcd For C13H9N2O4 257.23; Found 257.4; Anal. Calcd for
C13H10N2O4: C, 60.47; H, 3.90; N, 10.85. Found: C, 60.40; H, 3.86; N,
10.79.
4.2.16. 2,3-Dimethyl-1H-benzo[4,5]thieno[2,3-b]pyrrole (4p)
Yield 82% (417mg); White solid; mp: 234e235 C; IR (ATR,
cm1): 3369 (NH); 1H NMR (CDCl3, 400MHz) d: 2.00 (s, 3H), 2.29 (s,
3H), 5.05 (s, 1H, NH), 7.51 (t, 1H, J¼ 6.8 Hz, Ar-H), 7.70 (t, 1H,
J¼ 6.4 Hz, Ar-H), 7.99 (d, 1H, J¼ 9.2 Hz, Ar-H), 8.44 (d, 1H, J¼ 8.8 Hz,
Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 7.9, 11.2, 103.3, 122.9,
123.3, 124.0, 124.3 (2C), 126.2, 127.8, 139.8, 142.0 ppm; HRMS m/z:
[MþNa]þ Cald For C12H11NSNa 224.29; Found 224.2990; Anal. Calcd




Yield 90% (554mg); White solid; mp: 241e242 C; IR (ATR,
cm1): 3374 (NH); 1H NMR (CDCl3, 400MHz) d: 1.21 (s, 9H, tert-
butyl), 2.09 (s, 3H, CH3), 5.03 (s, 1H, NH), 7.38 (t, 1H, J¼ 7.6 Hz, Ar-
H), 7.51 (t, 1H, J¼ 6.4 Hz, Ar-H), 7.99 (d, 1H, J¼ 8.8 Hz, Ar-H), 8.30 (d,
1H, J¼ 9.2 Hz, Ar-H) ppm; 13C NMR (CDCl3, 100MHz) d: 11.8, 32.7
(3C), 33.9, 118.4, 122.6, 123.5, 124.0, 124.5 (2C), 126.7, 127.8, 139.9,
141.9 ppm; LCMS m/z: [MþH]þ Calcd For C15H18NS 244.27; Found
244.3; Anal. Calcd for C15H17NS: C, 74.03; H, 7.04; N, 5.76. Found: C,
73.98; H, 7.00; N, 5.69.
4.2.18. 1,2,3,4-Tetrahydrobenzo[4,5]thieno[2,3-b]cyclopenta[d]
pyrrole (4r)
Yield 83% (447mg); White solid; mp: 237e239 C; IR (ATR,
cm1): 3378 (NH); 1H NMR (CDCl3, 400MHz) d: 2.04e2.12 (m, 2H),
2.72 (t, 2H, J¼ 7.2 Hz), 3.19 (t, 2H, J¼ 6.4 Hz), 5.01 (s,1H, NH), 7.48 (t,
1H, J¼ 6.8 Hz, Ar-H), 7.69 (t, 1H, J¼ 7.6 Hz, Ar-H), 8.01 (d, 1H,
J¼ 8.8 Hz, Ar-H), 8.35 (d,1H, J¼ 9.6 Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 25.0 (2C), 28.1, 121.5, 122.4 (2C), 124.4 (3C), 126.2 (2C),
140.0, 142.3 ppm; LCMS m/z: [MþH]þ: Calcd For C13H12NS 214.30;
Found 214.3; Anal. Calcd for C13H11NS: 73.20; H, 5.20; N, 6.57.
Found: C, 73.14; H, 5.16; N, 6.50.
4.2.19. 2-Methyl-2,3,4,5-tetrahydro-1H-benzo[40,5']thieno[30,2':4,5]
pyrrolo[3,2-c]pyridine (4s)
Yield 84% (516mg); White solid; mp: 230e232 C; IR (ATR,
cm1): 3371 (NH); 1H NMR (CDCl3, 400MHz) d: 2.21 (s, 3H), 2.53 (t,
2H, J¼ 6.8 Hz), 2.92 (t, 2H, J¼ 6.4 Hz), 4.09 (s, 2H), 4.97 (s, 1H, NH),
7.65 (t, 1H, J¼ 7.2 Hz, Ar-H), 7.72 (t, 1H, J¼ 6 Hz, Ar-H), 7.89 (d, 1H,
P. Chacko, K. Shivashankar / Tetrahedron 74 (2018) 1520e15261526J¼ 9.6 Hz, Ar-H), 8.37 (d, 1H, J¼ 10Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 27.6, 44.0, 56.1, 57.3, 118.0, 122.3, 123.3, 124.1, 124.5,
125.1, 126.2 (2C), 139.4, 141.8 ppm; LCMS m/z: [MþH]þ Calcd For
C14H15N2S 243.34; Found 243.4; Anal. Calcd for C14H14N2S: C, 69.39;
H, 5.82; N, 11.56. Found: C, 69.31; H, 5.78; N, 11. 49.
4.2.20. 1,3,4,5-Tetrahydrobenzo[4,5]thieno[2,3-b]pyrano[3,4-d]
pyrrole (4t)
Yield 91% (528mg); Yellow solid; mp: 230e232 C; IR (ATR,
cm1): 3369 (NH); 1H NMR (CDCl3, 400MHz) d: 2.74 (t, 2H,
J¼ 7.6 Hz), 3.48 (t, 2H, J¼ 7.6 Hz), 4.50 (s, 2H), 5.04 (s, 1H, NH), 7.41
(t, 1H, J¼ 6.4 Hz, Ar-H), 7.60 (t, 1H, J¼ 6.8 Hz, Ar-H), 7.96 (d, 1H,
J¼ 9.6 Hz, Ar-H), 8.29 (d,1H, J¼ 9.2 Hz, Ar-H) ppm; 13C NMR (CDCl3,
100MHz) d: 26.4, 65.1, 65.6, 118.5, 122.8, 123.4, 124.0, 124.4 (2C),
126.5, 127.2, 139.8, 141.3 ppm; LCMS m/z:[MþH]þ Calcd For
C13H12NOS 230.3; Found 230.3; Anal. Calcd for C13H11NOS: C, 68.09;
H, 4.84; N, 6.11. Found: C, 68.01; H, 4.78; N, 6.04.
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